Nattrass Nicoli
AIDS and Society Research Unit, University of Cape Town, Private Bag Rondebosch 7701, Cape Town, South Africa.
J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):618-23. doi: 10.1097/01.qai.0000242456.05274.fb.
The number of people on highly active antiretroviral therapy (HAART) in South Africa has risen from < 2000 in October 2003, to almost 200,000 by the end of 2005. Yet South Africa's performance in terms of HAART coverage is poor both in comparison with other countries and the targets set by the government's own Operational Plan. The public-sector HAART "rollout" has been uneven across South Africa's nine provinces and the role of external assistance from NGOs and funding agencies such as the Global Fund and PEPFAR has been substantial. The National Treasury seems to have allocated sufficient funding to the Department of Health for a larger HAART rollout, but the Health Minister has not mobilized it accordingly. Failure to invest sufficiently in human resources--especially nurses--is likely to constrain the growth of HAART coverage.
在南非，接受高效抗逆转录病毒疗法（HAART）治疗的人数已从2003年10月的不到2000人，增至2005年底的近20万人。然而，无论是与其他国家相比，还是与政府自身业务计划设定的目标相比，南非在HAART覆盖方面的表现都很差。公共部门的HAART“推广”在南非九个省份中参差不齐，非政府组织以及全球基金和美国总统防治艾滋病紧急救援计划（PEPFAR）等资助机构的外部援助发挥了重要作用。国家财政部似乎已向卫生部拨出足够资金用于更大规模的HAART推广，但卫生部长并未相应地调动这些资金。在人力资源——尤其是护士方面投资不足，可能会限制HAART覆盖范围的扩大。
